Literature DB >> 21901339

New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy.

Geraldo Bezerra da Silva1, Alexandre Braga Libório, Elizabeth De Francesco Daher.   

Abstract

Sickle cell nephropathy is one of the main chronic complications of sickle cell disease (SCD), the most common of the hematological hereditary disorders. Several studies have been performed since the first description of SCD 100 years ago to investigate the mechanisms of kidney involvement in this disease. It has been demonstrated that both glomerular and tubular compartments can be damaged as a direct consequence of SCD, including renal function loss, concentration and acidification deficits, and glomerulopathies. This article highlights the aspects of sickle cell nephropathy pathophysiology and clinical manifestations and describes the most recent advances in the diagnosis and treatment of this disorder.

Entities:  

Mesh:

Year:  2011        PMID: 21901339     DOI: 10.1007/s00277-011-1327-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  12 in total

Review 1.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

Review 2.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

Review 3.  Cardiovascular complications in patients with sickle cell disease.

Authors:  Mark T Gladwin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

5.  Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent.

Authors:  Geraldo B Silva Junior; Ana Patrícia F Vieira; Amanda X Couto Bem; Marília P Alves; Gdayllon C Meneses; Alice M C Martins; Sonia M H A Araújo; Alexandre V Libório; Elizabeth F Daher
Journal:  Int J Clin Pharm       Date:  2014-06-17

6.  A novel case report of sickle cell disease-associated immunoglobulin A nephropathy: the diagnostic value of erythrocyte dysmorphism evaluation.

Authors:  Gyl Eb Silva; André C Teixeira; José Gg Vergna; Natalino Salgado-Filho; Leandro Z Crivellentti; Roberto S Costa; Márcio Dantas
Journal:  Int J Clin Exp Med       Date:  2014-06-15

Review 7.  Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment.

Authors:  Essa Hariri; Anthony Mansour; Andrew El Alam; Yazan Daaboul; Serge Korjian; Sola Aoun Bahous
Journal:  Int Urol Nephrol       Date:  2018-01-30       Impact factor: 2.370

Review 8.  Travelers with sickle cell disease.

Authors:  Shaina M Willen; Courtney D Thornburg; Paul M Lantos
Journal:  J Travel Med       Date:  2014-06-19       Impact factor: 8.490

9.  Kidney dysfunction and beta S-haplotypes in patients with sickle cell disease.

Authors:  Lilianne Brito da Silva Rocha; Geraldo Bezerra da Silva Jn; Elizabeth de Francesco Daher; Hermano Alexandre Lima Rocha; Darcielle Bruna Dias Elias; Romélia Pinheiro Gonçalves
Journal:  Rev Bras Hematol Hemoter       Date:  2013

10.  Evaluation of renal function in sickle cell disease patients in Brazil.

Authors:  G B Silva Junior; A B Libório; A P F Vieira; A X Couto Bem; A S Lopes Filho; A C Figueiredo Filho; A L M O Guedes; J H Souza; C M B E Costa; R Costa; E F Daher
Journal:  Braz J Med Biol Res       Date:  2012-05-17       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.